0000899243-22-027629.txt : 20220803 0000899243-22-027629.hdr.sgml : 20220803 20220803174530 ACCESSION NUMBER: 0000899243-22-027629 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220301 FILED AS OF DATE: 20220803 DATE AS OF CHANGE: 20220803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Habibizad Nazila CENTRAL INDEX KEY: 0001913961 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37539 FILM NUMBER: 221133898 MAIL ADDRESS: STREET 1: C/O GLOBAL BLOOD THERAPEUTICS, INC. STREET 2: 181 OYSTER POINT BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc. CENTRAL INDEX KEY: 0001629137 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274825712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 181 OYSTER POINT BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650741-7700 MAIL ADDRESS: STREET 1: 181 OYSTER POINT BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0206 3/A 2022-03-01 2022-03-03 0 0001629137 Global Blood Therapeutics, Inc. GBT 0001913961 Habibizad Nazila C/O GLOBAL BLOOD THERAPEUTICS, INC. 181 OYSTER POINT BOULEVARD. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 See Remarks Common Stock 10528 D Amendment filed to correct the number of shares reported as beneficially owned by the Reporting Person on her original Form 3, which inadvertently overstated the number of shares held. The overstatement was carried forward on the Reporting Person's subsequent filed Forms 4. Executive Vice President, Operations /s/ Miguel Carrillo, Attorney-in-Fact 2022-08-03